Evoke Pharma Announces Proposed Public Offering of Common Stock
January 13, 2021 16:02 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases,...
Evoke Pharma Announces Positive Findings from GIMOTI™ Market Research Study
January 13, 2021 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (“Evoke” or the “Company”) (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal...
Evoke Pharma Reports Third Quarter 2020 Financial Results
November 10, 2020 08:30 ET
|
Evoke Pharma, Inc.
Gimoti™ commercial launch underway SOLANA BEACH, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for...
Evoke and EVERSANA Announce Commercial Launch of Gimoti™
October 26, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif. and CHICAGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases,...
Evoke Pharma to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference
September 09, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma and EVERSANA Announce the Appointment of Christopher Quesenberry as Chief Commercial Officer for Gimoti™
August 25, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif. and CHICAGO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases and...
Evoke Pharma Reports Second Quarter 2020 Financial Results
August 06, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma Initiates Commercial Manufacturing of Gimoti™
July 15, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma Extends Cash Runway to 2Q 2021
July 08, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
FDA Approves Evoke’s GIMOTI™
June 19, 2020 15:32 ET
|
Evoke Pharma, Inc.
Commercial Partner EVERSANA Prepares for GIMOTI LaunchEvoke Extends Cash Runway into 2021 SOLANA BEACH, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty...